North America Continuous Positive Airway Pressure (CPAP) Devices Market Growth by 2027

The North America continuous positive airway pressure (CPAP) devices Market is expected to reach US$2,007.22 million by 2027from US$ 1,083.41 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.

 The growth of the market is driven by the factors such as, increasing prevalence of sleep apnea,  respiratory disorders, rising number of geriatric population, and increasing prevalence of obesity. However, the market is likely to have negative impact due to high cost of CPAP machines and negative effect of device.such as its nearly impossible for the middle class to effort CPAP machine.

The continuous positive airway pressure (CPAP) is a treatment for obstructive apnea. CPAP device uses air pressure to keep the airways open, and it is typically used by patients who have breathing problems during sleep. The device helps people with apnea to breathe easily and frequently while sleeping. For instance, NXP technology manufactures CPAP machines for sleep apnea, which prevent muscles in the respiratory system from obstructing the airway. CPAP machines maintain constant airflow by continuously monitoring system pressure in conjunction with ventilator motor control speed regulation. According to the American Sleep Association (ASA), insomnia or sleeplessness is the most common sleep disorder with short term issues reported among 30% of adults and chronic insomnia among 10% of adults. The US is the most important revenue contributor due to the increased diagnosis of apnea among patients. According to the World Health Organization (WHO) report of 2016, more than 1.9 billion adults, above 18 years of age were overweight. Out of these over 650 million people were obese. The report also suggests that over 340 million children and adolescents aged between 5 and 19 years were overweight or obese in 2016. According to the American Sleep Association, 50 to 70 million US adults have a sleep disorder and in 2016 around 3.8% of the total adult populations in the US werediagnosed with chronic bronchitis. Moreover, the continuous positive airway pressure (CPAP) is currently the most widespread and effective therapy for sleep-breathing and respiratory disorders. According to the summary of Health Statistics National Health Interview Survey, in 2018, nine million people were diagnosed with chronic bronchitis in the US. Thus, increasing prevalence of sleep apnea and respiratory disorders is driving the North America continuous positive airway pressure (CPAP) devices market.

North America Continuous Positive Airway Pressure (CPAP) Devices Market Revenue and Forecast to 2027 (US$ Mn)

North AmericaContinuous Positive Airway Pressure (CPAP) Devices Market – Market Segmentation

By Type

• Automatic
• Manual

By EndUser

• Hospital
• Emergency Health Departments

By Country

• North America

  • US
  • Canada
  • Mexico

Company Profiles

• Koninklijke Philips N.V.
• Cardinal Health Inc
• Smith’s Group plc
• ResMed
• 3B Medical Inc
• Airing
• Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC
• Somnetics International, Inc.
• Sleepnet Corporation.
• Circadiance

North America Continuous Positive Airway Pressure (CPAP) Devices Report Scope